When young patients develop juvenile systemic sclerosis (JSSc), it is vital to monitor them for changes in cardiopulmonary parameters that…
Articles by Maureen Newman
It is widely accepted that hypertrophic mesenchymal stem cells contribute to pulmonary arterial hypertension (PAH) in individuals with systemic…
Boehringer Ingelheim, a leader in the pharmaceuticals industry, recently received a positive opinion from the Committee for Medicinal Products…
Pulmonary hypertension (PH) is uniformly defined as high pressure in the pulmonary vasculature but can be divided into three…
Combining two drug therapies, statins and imatinib, may be more beneficial for pulmonary hypertension management than using either alone.
Although riociguat is indicated for treatment of pulmonary hypertension, Bayer HealthCare…
Patients with systemic sclerosis hoping to enroll in clinical trials investigating hematopoietic stem cell transplantation may be disqualified if…
In a perfect world, equivalent responses to treatments from patients with pulmonary hypertension would make all treatment outcomes predictable…
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) who respond differently to treatment with pulmonary endarterectomy (PEA) may have…
While the majority of individuals suspected of having pulmonary hypertension would prefer to receive a physical examination to confirm…
Naturally occurring microRNA molecules (miRNA) hold the potential to be a new treatment for pulmonary artery disease. A group…
At the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Giessen University, a team of…